04/10/2024
3:05 PM | Arbutus Biopharma (Filer)
| Form DEF 14A | |
04/10/2024
3:06 PM | Arbutus Biopharma (Filer)
| Form DEFA14A | |
04/04/2024
7:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:41 AM | Arbutus Biopharma (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/05/2024
6:54 PM | Arbutus Biopharma (Issuer)
McElhaugh Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:54 PM | Arbutus Biopharma (Issuer)
Sofia Michael J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/05/2024
6:54 PM | Arbutus Biopharma (Issuer)
HASTINGS DAVID C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:55 PM | Arbutus Biopharma (Issuer)
Sims Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:55 PM | Arbutus Biopharma (Issuer)
Naftzger J. Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:09 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
7:00 AM | Arbutus Biopharma (Subject)
Two Seas Capital LP (Filed by)
| Form SC 13G | |
11/07/2023
3:18 PM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:16 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
7:06 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
4:07 PM | Arbutus Biopharma (Subject)
Whitefort Capital Management, LP (Filed by)
| Form SC 13G | |
09/11/2023
3:16 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:11 PM | Arbutus Biopharma (Issuer)
Rewolinski Melissa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
3:13 PM | Arbutus Biopharma (Issuer)
Rewolinski Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:48 PM | Arbutus Biopharma (Issuer)
Sims Karen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
3:50 PM | Arbutus Biopharma (Issuer)
Sims Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:10 PM | Arbutus Biopharma (Issuer)
Naftzger J. Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
3:12 PM | Arbutus Biopharma (Issuer)
Naftzger J. Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
3:02 PM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
6:31 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
5:10 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
5:00 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2023
3:22 PM | Arbutus Biopharma (Issuer)
BURGESS DANIEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
3:27 PM | Arbutus Biopharma (Issuer)
HENRIQUES RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
3:07 PM | Arbutus Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:32 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
5:00 AM | Arbutus Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
